Page last updated: 2024-08-23

raloxifene hydrochloride and Adrenal Cancer

raloxifene hydrochloride has been researched along with Adrenal Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Reincke, M	1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Adrenal Cancer

Article	Year
[Diabetes, Conn syndrome and osteoporosis. What is new in diagnosis and therapy?]. MMW Fortschritte der Medizin, 2003, Feb-27, Volume: 145, Issue:9 Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diphosphonates; Estrogen Antagonists; Female; Fractures, Bone; Humans; Hyperaldosteronism; Hyperglycemia; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators	2003

Article

Year

[Diabetes, Conn syndrome and osteoporosis. What is new in diagnosis and therapy?].

MMW Fortschritte der Medizin, 2003, Feb-27, Volume: 145, Issue:9

Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diphosphonates; Estrogen Antagonists; Female; Fractures, Bone; Humans; Hyperaldosteronism; Hyperglycemia; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators

2003